These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19931593)

  • 1. Association analysis between functional polymorphism of the rs4606 SNP in the RGS2 gene and antipsychotic-induced Parkinsonism in Japanese patients with schizophrenia: results from the Juntendo University Schizophrenia Projects (JUSP).
    Higa M; Ohnuma T; Maeshima H; Hatano T; Hanzawa R; Shibata N; Sakai Y; Suzuki T; Arai H
    Neurosci Lett; 2010 Jan; 469(1):55-9. PubMed ID: 19931593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication.
    Greenbaum L; Strous RD; Kanyas K; Merbl Y; Horowitz A; Karni O; Katz E; Kotler M; Olender T; Deshpande SN; Lancet D; Ben-Asher E; Lerer B
    Pharmacogenet Genomics; 2007 Jul; 17(7):519-28. PubMed ID: 17558307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3'-untranslated region.
    Greenbaum L; Smith RC; Rigbi A; Strous R; Teltsh O; Kanyas K; Korner M; Lancet D; Ben-Asher E; Lerer B
    Pharmacogenomics J; 2009 Apr; 9(2):103-10. PubMed ID: 18347610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia.
    Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Huang CH; Tsai GE
    J Clin Psychopharmacol; 2008 Feb; 28(1):64-8. PubMed ID: 18204343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polymorphism of RGS2 gene: genetic markers of risk for schizophrenia and pharmacogenetic markers of typical neuroleptics efficiency].
    Gareeva AE; Zakirov DF; Valinurov RG; Khusnutdinova EK
    Mol Biol (Mosk); 2013; 47(6):934-41. PubMed ID: 25509855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
    Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.
    Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence for an association between G protein beta3 subunit gene C825T polymorphism and tardive dyskinesia in schizophrenia.
    Lee HJ; Kang SG; Paik JW; Lee MS; Cho BH; Park YM; Kim W; Choi JE; Jung IK; Kim L; Lee MS
    Hum Psychopharmacol; 2007 Dec; 22(8):501-4. PubMed ID: 17726725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between antipsychotic-induced Parkinsonism or its subsymptoms and rs4606 SNP of RGS2 gene in African-Caribbeans and the possible role of the medication: the Curacao extrapyramidal syndromes study X.
    Al Hadithy AF; Wilffert B; Bruggeman R; Stewart RE; Brouwers JR; Matroos GE; Hoek HW; van Harten PN
    Hum Psychopharmacol; 2009 Mar; 24(2):123-8. PubMed ID: 19156702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel missense polymorphism in the regulator of G-protein signaling 10 gene: analysis of association with schizophrenia.
    Hishimoto A; Shirakawa O; Nishiguchi N; Aoyama S; Ono H; Hashimoto T; Maeda K
    Psychiatry Clin Neurosci; 2004 Oct; 58(5):579-81. PubMed ID: 15482592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of RGS2 gene polymorphisms with panic disorder in Japanese.
    Mouri K; Hishimoto A; Fukutake M; Nishiguchi N; Shirakawa O; Maeda K
    Kobe J Med Sci; 2010 Apr; 55(5):E116-21. PubMed ID: 20847599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK; Zalar B; Breskvar K; Dolzan V
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia.
    Hamdani N; Tabeze JP; Ramoz N; Ades J; Hamon M; Sarfati Y; Boni C; Gorwood P
    Eur Neuropsychopharmacol; 2008 Jan; 18(1):34-40. PubMed ID: 17669634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association between dopamine D4 receptor gene -521 C/T polymorphism and tardive dyskinesia in schizophrenia.
    Lee HJ; Kang SG; Choi JE; Paik JW; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2007; 55(1):47-51. PubMed ID: 17556853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophrenia -- Juntendo University Schizophrenia Projects (JUSP).
    Maeshima H; Ohnuma T; Sakai Y; Shibata N; Baba H; Ihara H; Higashi M; Ohkubo T; Nozawa E; Abe S; Ichikawa A; Nakano Y; Utsumi Y; Suzuki T; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1410-8. PubMed ID: 17669570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
    Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms.
    Kwon JS; Joo YH; Nam HJ; Lim M; Cho EY; Jung MH; Choi JS; Kim B; Kang DH; Oh S; Park T; Hong KS
    Arch Gen Psychiatry; 2009 Nov; 66(11):1233-41. PubMed ID: 19884611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders.
    Kim JH; Jung HY; Kang UG; Jeong SH; Ahn YM; Byun HJ; Ha KS; Kim YS
    Mov Disord; 2002 Nov; 17(6):1354-9. PubMed ID: 12465082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RGS2 C1114G polymorphism and body weight gain in hypertensive patients.
    Sartori M; Ceolotto G; Dorigatti F; Mos L; Santonastaso M; Bratti P; Papparella I; Semplicini A; Palatini P;
    Metabolism; 2008 Mar; 57(3):421-7. PubMed ID: 18249218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism C1114G of gene encoding the cardiac regulator of G-protein signaling 2 may be associated with number of episodes of neurally mediated syncope.
    Lelonek M; Pietrucha T; Matyjaszczyk M; Goch JH
    Arch Med Res; 2009 Apr; 40(3):191-5. PubMed ID: 19427970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.